Prognosys Biosciences
(This story has been updated to correct a description of the company's technology.)
Prognosys Biosciences has developed a cDNA-based system for coding customized peptide libraries and has begun offering it commercially as a research tool.
The European Bioinformatics Institute has launched the Enzyme Portal, a free resource for researchers studying the biology of enzymes and proteins with enzymatic activity.
Febit plans to debut the method at Cambridge Healthtech Institute's Next-Generation Sequencing conference in San Diego next month.